Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 235

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study

Open access
Li, Xiao-Ning, Huang, Yong, Wang, Wen, Jing, Qin-Long, Zhang, Chun-Huan, Qin, Peng-Zhe, Guan, Wei-Jie, Gan, Lin, Li, Yi-Lan, Liu, Wen-Hui, Dong, Hang, Miao, Yu-Tian, Fan, Shu-Jun, Zhang, Zhou-Bin, Zhang, Ding-Mei, Zhong, Nan-Shan·2021·Emerging Microbes & Infections

Abstract

The effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant, which has been associated with greater transmissibility and virulence, remains unclear. We conducted a test-negative case–control study to explore the vaccine effectiveness (VE) in real-world settings. We recruited participants aged 18–59 years who consisted of SARS-CoV-2 test-positive cases (n = 74) and test-negative controls (n = 292) during the outbreak of the Delta variant in May 2021 in Guangzhou city, China. Vaccination status was compared to estimate The VE of SARS-CoV-2 inactivated vaccines. A single dose of inactivated SARS-CoV-2 vaccine yielded the VE of only 13.8%. After adjusting for age and sex, the overall VE for two-dose vaccination was 59.0% (95% confidence interval: 16.0% to 81.6%) against coronavirus disease 2019 (COVID-19) and 70.2% (95% confidence interval: 29.6–89.3%) against moderate COVID-19 and 100% against severe COVID-19 which might be overestimated due to the small sample size. The VE of two-dose vaccination against COVID-19 reached 72.5% among participants aged 40–59 years, and was higher in females than in males against COVID-19 and moderate diseases. While single dose vaccination was not sufficiently protective, the two-dose dosing scheme of the inactivated vaccines was effective against the Delta variant infection in real-world settings, with the estimated efficacy exceeding the World Health Organization minimal threshold of 50%.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/22221751.2021.1969291

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 235

Metadata

Authors
Li, X.-N., Huang, Y., Wang, W., Jing, Q.-L., Zhang, C.-H., Qin, P.-Z., Guan, W.-J., Gan, L., Li, Y.-L., Liu, W.-H., Dong, H., Miao, Y.-T., Fan, S.-J., Zhang, Z.-B., Zhang, D.-M., & Zhong, N.-S.
Venue
Emerging Microbes & Infections
Published
2021-01
Volume
10
Issue
1
Pages
1751-1759
ISSN
2222-1751 (ISSN-L)
OpenAlex
W3194599195
Cited by
235
References
9
FWCI
17.10
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study. https://app.cochat.ai/papers/10.1080/22221751.2021.1969291
The paper
Li, X.-N., Huang, Y., Wang, W., Jing, Q.-L., Zhang, C.-H., Qin, P.-Z., Guan, W.-J., Gan, L., Li, Y.-L., Liu, W.-H., Dong, H., Miao, Y.-T., Fan, S.-J., Zhang, Z.-B., Zhang, D.-M., & Zhong, N.-S. (2021). Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study. Emerging Microbes & Infections. https://doi.org/10.1080/22221751.2021.1969291

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.